Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Breast Neoplasms 5Neoplasm Metastasis 3Stomach Neoplasms 2Advanced Solid Tumors 2Urinary Bladder Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Triple Negative Breast Neoplasms 1Solid Tumors 1Solid Tumor 1Rectal Neoplasms 1Prostatic Neoplasms 1Melanoma 1Colorectal Neoplasms 1Colonic Neoplasms 1Carcinoma, Transitional Cell 1Adenocarcinoma of the Stomach 1

Interventions

PR-104 3apomine 2N-(4-(3-(1H-1,2,4-triazol-1-yl)-4-(3,4,5-trimethoxybenzoyl)phenyl)thiazol-2-yl)-2-amino-3-methylbutanamide 2tesetaxel 1ixabepilone 1intoplicine 1fluoromisonidazole 1eribulin 1bempegaldesleukin 1HhAntag691 1Granulocyte Colony-Stimulating Factor 1Gemcitabine 1Filgrastim 1Docetaxel 1Capecitabine 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Unspecified Adult Solid Tumor, Protocol Specific × tesetaxel × Clear all
NCT00077077 2012-05-16

DJ-927 and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors

Daiichi Sankyo

Phase 1 Completed
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡